Non-small cell lung cancer with EGFR exon 20 insertion mutation

Non-small cell lung cancer with EGFR exon 20 insertion mutation represents a distinct molecular subset of non-small cell lung cancer characterized by in-frame duplications or insertions within exon 20 of the epidermal growth factor receptor gene Pathophysiologically, the insertion alters the conformation of the kinase domain's alpha-C-helix and phosphate-binding loop, locking the receptor into a constitutively active state that drives malignant cell proliferation and survival Unlike classic sens...

Non-small cell lung cancer with EGFR exon 20 insertion mutation represents a distinct molecular subset of non-small cell lung cancer characterized by in-frame duplications or insertions within exon 20 of the epidermal growth factor receptor gene

Primarily affecting the pulmonary epithelial tissue, these alterations typically occur in adenocarcinomas and are enriched among non-smokers and female patients Unlike classic sensitizing EGFR alterations, these structural changes sterically restrict the drug-binding pocket, conferring intrinsic de novo resistance to first-, second-, and third-generation tyrosine kinase inhibitors

Primarily affecting the pulmonary epithelial tissue, these alterations typically occur in adenocarcinomas and are enriched among non-smokers and female patients

Pathophysiologically, the insertion alters the conformation of the kinase domain's alpha-C-helix and phosphate-binding loop, locking the receptor into a constitutively active state that drives malignant cell proliferation and survival